ACP-01, autologous angiogenic precursor cells for cardiac diseases

ACP-01 is a product comprised of ex vivo-expanded autologous angiogenic peripheral blood-derived precursor cells, for the treatment of angina pectoris and congestive heart failure. The treatment was found to be safe in a small-scale clinical trial and improved symptoms in patients.